Digital Novel Coronavirus Investment Forum

Web-Seminar
Web-Seminar
EMPOWERING EARLY STAGE INNOVATION

 

The Digital Novel Coronavirus Investment Forum is a forward-looking analysis of the revolution in healthcare caused by the pandemic and the consequent exciting drive for innovation in the Life Sciences, HealthTech and Digital sectors. The virtual NCIF conference is going to take place on the 7th-9th of July with main programme being spread throughout 3 days. Our programme has over ten hours of high-level speeches and panel discussions across 2 ½ days. In addition, there is a global company showcase of 40+ presentations by corporates, offering innovative solutions and looking for capital and partnerships. The Emerging Technologies companies showcase features either 5 or 10 minute pre-recorded presentations available on the event’s portal. There is also a limited number of 20-minute presentations for more developed companies, which are going to be broadcasted live during the main programme and additionally will have a Contributing Supporter’s branding. Confirmed sponsor includes: Silver Sponsor is EIT Health e.V, an EU agency mandated to support early stage innovation in healthcare, who is going to present 20 of their companies as part of the showcase.  Other sponsors will be announced shortly. For the digital event, we are using Online Meeting System, which will facilitate the interaction of entrepreneurs and potential partners and investors.

Plenary Sessions on the 7th of July Include:

  • Reflections on the Pandemic Panel
  • The Future of Public Health Post Pandemic: Digital Health & AI at the Forefront Change Panel
  • Challenges of Testing Panel
  • MedTech Innovation Panel


Plenary Sessions on the 8th of July Include:

  • Public/ Private Partnerships: New Landscape Panel
  • Vaccines Roundtable
  • Potential Therapeutic Strategies to Prevent and Conquer Covid-19 Panel
  • Investors in the Time of the Pandemic Panel


Plenary Sessions on the 9th of July Include:

  • China Innovation Panel
  • Israeli Responses to the Pandemic Panel
  • Concluding Session of the Forum


Confirmed Keynote Speakers Include:

  • Prof. Ran Balicer, MD, PhD, MPh, Chief Innovation Officer, Clalit Research Institute
  • Uli Grabenwarter, Deputy Director - Equity Investments, European Investment Fund


Provisional Speakers & Chairs Include:

  • Ashish Patel, Principal, Optum Ventures
  • Bernd Goergen, Partner, High-Tech Gründerfonds Management GmbH                      
  • Bibhash Mukhopadhyay, Principal, New Enterprise Associates (NEA)        
  • Bin Sheng, Investment Professional, SDIC Fund Management Co., Ltd*                   
  • David Gordon, Head of Investments, Longliv Ventures     
  • Florian Schödel, Owner, Philimmune, LLC             
  • Guy Spigelman, Healthcare & Life Sciences Business Development, Amazon Web Services
  • Jeffrey Cohen, Managing Director, Equity Research, Ladenburg Thalmann & Co. Inc.*
  • John Pissanos, Executive Director - Healthcare Investment Banking, J.P. Morgan
  • Prof. Josef Penninger, Director of Life Science Institute, The University of British Columbia
  • Laurent Choppe, Managing Partner, Cukierman & Co. Life Sciences           
  • Meredith Fisher, Partner, Partners HealthCare Innovation                          
  • Michael Altorfer, CEO, Swiss Biotech Association              
  • Nate Beyor, Managing Director & Partner, Boston Consulting Group Digital Ventures
  • Nazar Rasul, Global Head Technology & Innovation Strategy, Siemens Healthineers AG
  • Oliver Schacht, CEO, Curetis N.V. 
  • Patrick Pfeffer, CEO, aescuvest international GmbH
  • Ran Balicer, Director,  Clalit Research Institute
  • Rao Movva, Novartis Distinguished Scientist & Independent Pharma & Biotech Advisor
  • Regina Hodits, Managing Partner, Wellington Partners
  • Uli Grabenwarter, Deputy Director - Equity Investments, European Investment Fund
  • Ulrich Schubert, Research Group Leader, Institute of Clinical and Molecular Virology*
  • Yuwen Liu, BOHE Angel Fund, Founding Partner
  • TBA, EIT Health e.V. 
  • More TBA..

HOW TO PARTICIPATE AS AUDIENCE
 
For the event we will be using 2 platforms: Online Meeting System (Meeting Mojo) designed for One-2-One meetings and Event’s Portal, where you are able to find all information related to the event and view live event’s programme including showcases. The Online Meeting System will open on 29th of June for building profiles and sending meeting invites. Meetings will take place from 6th to 10th of July between 8.00 - 20.00 (GMT +2). System will allow you to have a secure audio/video call, as well as option to present slides using screen share function. Meetings will last for 30 minutes.
 
Free access to view panel discussions and presentations is provided to all interested participants. This will allow us to increase the size of the audience and provide a higher exposure for participating companies.
 
Premium Online Meeting System Access will be provided complimentary for qualified institutional (buy/sell-side), private equity and venture investors and also for partnering & licensing executives representing big pharma. The number of passes is limited, and priority is given to regular participants, however organizer has the discretion to reject passes. Other participants will receive complimentary listing of their profiles on the Online Meeting System, including 1 invitation free of charge. Should a company be interested in a higher exposure, they may consider purchasing Basic, Advanced and Premium Online Meeting System Access with an option for a pre-recorded showcase presentation. Number of meeting invites defines how many requests can be sent. If meeting invite is declined, you will receive an invite credit back that can be reused. Number of invites does not restrict how many meeting invitations you can receive.

ENQUIRIES TO PRESENT AND SPONSOR

​Presenting at the forum offers excellent opportunities to showcase your company to some of the leading global investors and corporates. It will offer you the opportunity to communicate your projected capital raising plans or simply help you in finding the right partner for your business. Presenting companies from Europe, US, China and Israel will benefit from specially designed panels and keynotes from leading industry figures as well as access to some of the leading analysts and investors from Europe and beyond.
 
For those interested to join the companies showcase there is an option to purchase either a 5 or 10 minute presentation, which will be pre-recorded in advance and available to all registered attendees before, during and after the conference on the event’s portal. There is also a limited number of 20-min presentations with a Contributing Supporters branding, which will be pre-recorded and broadcasted live during the main programme on the 9th of July. The Sachs team can assist with the pre-recording of the presentation or you can upload a video you already have. Interested viewers will be able to message or request a meeting with you using the Online Meeting System.
 
For those who are interested in higher exposure, we could suggest to become an event’s sponsor. Sponsorship packages are designed for each client specifically and in addition to sponsor branding could include delegate passes with Premium Online Meeting System Access, speaking or co-chairing opportunity as part of the programme, keynote or 3-min advertisement shown in between the panels, and discounts for clients or option to nominate them for the showcase. 

Sachs Associates has developed an extensive knowledge of the key individuals operating within the European and global biotech industry. This together with a growing reputation for excellence puts Sachs Associates at the forefront of the industry and provides a powerful tool by which to increase the position of your company in this market.

To learn more about presenting or sponsorship opportunities, please contact:

Silvia Kar on + 44 (0)203 463 4890 or by email: 
Silvia